We saw a significant reframing of the companies future looking statement ...
Gone is the LG 40 compassionate patients a month thats he`s banged on about since 2020 ...
Now its about licensing, which is what I believed all along ( 19 employees , no expertise , no sales , no distribution etc etc )
Their `licensing ` PR was :
a) A heads up to the great unwashed that their tack had changed ..
b) A heads up that they are already talking to large pharma about participation..
c) An invitation for us to speculate ( correctly ) that any license conversation would 100% also have a buyout side chat incorporated..
d) A licensing agreement is often a place holder for milestones leading to buyout .
I am sure of all of the above .